Climb Bio Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | +428.6% | +87.1% | +83.2% | -56.6% | +44.9% | |
| – | – | – | – | +1,692.4% | -54.9% | -135.4% | |
| – | – | – | – | – | – | – | |
| – | – | -1,523.2% | – | +100.3% | -275.5% | – | |
| – | -81.2% | +3,498.6% | -100.0% | – | +15,444.5% | -100.0% | |
| – | -103.5% | – | -112.6% | – | -111.9% | – | |
| – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.